The healthcare and life sciences sectors are now bracing for
Domestic production gets a boost as India steps closer to
India Strengthens Pharmaceutical Self-Reliance Through Production Linked Incentive (PLI) Scheme
Government’s Initiative to Reduce Import Dependence on China and Boost Domestic API ManufacturingThe Government of India is taking decisive steps to enhance domestic manufacturing
India’s Health Ministry Intensifies Surveillance Amid China’s HMPV Concerns
In response to reports of a human metapneumovirus (HMPV) outbreak in China, India's Ministry of Health and Family Welfare has heightened surveillance of respiratory
Breakthrough in Breast Cancer Treatment: Researchers Develop Injectable Hydrogel for Precision Therapy
Researchers from the Indian Institute of Technology (IIT) Guwahati, in collaboration with Bose Institute Kolkata, have unveiled a revolutionary injectable hydrogel designed to transform
Clariant introduces new high-performing excipients at the CPHI India 2024 trade show
Clariant is excited to present the company’s latest portfolio of products for the healthcare industry at the upcoming CPHI India tradeshow in Delhi NCR
India Poised to Capture 8-10% of Global CDMO Market by 2033, McKinsey
India is on track to potentially account for 8-10% of the global market share in Contract Research, Development, and Manufacturing Organizations (CDMOs) by 2033,
Indian Pharma Industry Expected to See 8.5% Revenue Growth Driven by Domestic and US Markets
Axis Securities Report Highlights Positive Trends for Q2 FY25The Indian pharmaceutical industry is poised for a robust year, with revenue growth projected at 8.5%